Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration.

Stefania Elena Navone(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Giovanni Marfia(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Amedeo Giannoni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Matteo Beretta(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Laura Guarnaccia(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Roberta Gualtierotti(Istituto Ortopedico Gaetano Pini), Daniele Nicoli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Paolo Rampini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Rolando Campanella(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
PubMed
June 1, 2017
Cited by 154Open Access
Full Text

Abstract

Intervertebral disc (IVD) degeneration (IDD) is one of the major causes of back pain, a condition that represents a serious socio-economic burden. Deeper knowledge of the complex and fine relationship between IVD degeneration, tissue inflammation and pain, appears to be critical to improve the current therapies, which have so far proven themselves ineffective. Upon degeneration, IVD tissues become inflamed, and this inflammatory microenvironment is associated with a cascade of degenerative events that may eventually cause discogenic pain. In particular, several studies have highlighted the major role of a number of proinflammatory mediators not only in the onset of the inflammatory condition, but also in the development of IDD in general. In this review, we will present the main pathological events that occur during disc degeneration, focusing on the relationship between the abnormal inflammatory milieu of the degenerating IVD, IDD and the generation of pain. Finally, we will present the current therapies for the treatment of IDD and low back pain, and the perspectives of future, more effective therapies.


Related Papers

No related papers found

Powered by citation graph analysis